Showing results (21-30 of 66) with videos related to
Sort By:
Pageof 7
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 31, 2015
Single Daily Busulfan Dosing for Infants with Nonmalignant Diseases Undergoing Reduced-Intensity Conditioning for Allogeneic Hematopoietic Progenitor Cell TransplantationJessica Ward, Morris Kletzel, Reggie Duerst, et al.Pediatric Transplantation|September 18, 2002
Induction of a transient graft vs. leukemia effect following unrelated cord blood transplantationPaul R Haut, Lydia Gonzalez-Ryan, Ling-Jia Wang, et al.Journal of Pediatric Hematology/Oncology|May 7, 2008
Sequential oral hydroxyurea and intravenous cytosine arabinoside in refractory childhood acute leukemia: a pediatric oncology group phase 1 studyRonald Dubowy, Michael Graham, Nasrollah Hakami, et al.Journal of Pediatric Hematology/Oncology|December 7, 2002
Novel therapeutic approaches in the treatment of children with hepatoblastomaHoward M Katzenstein, Cynthia Rigsby, Peter H Shaw, et al.Pediatric Blood & Cancer|June 30, 2012
Feasibility of a tandem autologous peripheral blood stem cell transplant regimen for high risk neuroblastoma in a cooperative group setting: a Pediatric Oncology Group study: a report from the Children's Oncology GroupMeaghan Granger, Stephan A Grupp, Morris Kletzel, et al.Journal of Pediatric Hematology/Oncology|May 25, 2017
Late Effects in Pediatric High-risk Neuroblastoma Survivors After Intensive Induction Chemotherapy Followed by Myeloablative Consolidation Chemotherapy and Triple Autologous Stem Cell TransplantsAmy E Armstrong, Karina Danner-Koptik, Shannon Golden, et al.Pediatric Hematology and Oncology|January 26, 2019
High-dose chemotherapy and autologous hematopoietic stem-cell rescue for treatment of relapsed and refractory Wilms tumor: Re-evaluating outcomesJenna Rossoff, William T Tse, Reggie E Duerst, et al.Pediatric Blood & Cancer|February 15, 2008
A prospective longitudinal multicenter study of coagulation in pediatric patients undergoing allogeneic stem cell transplantationLeonardo R Brandão, Morris Kletzel, Farid Boulad, et al.Pediatrics|February 3, 2004
Nonmyeloablative hematopoietic stem cell transplant for X-linked hyper-immunoglobulin m syndrome with cholangiopathyDavid A Jacobsohn, Karan M Emerick, Paul Scholl, et al.Pediatric Blood & Cancer|May 22, 2021
Reduced-toxicity conditioning regimen with busulfan, fludarabine, rATG, and 400 cGy TBI in pediatric patients undergoing hematopoietic stem cell transplant for high-risk hematologic malignanciesJenna Rossoff, David Jacobsohn, Soyang Kwon, et al.Pageof 7